USNA Stock Analysis: Buy, Sell, or Hold?
USNA - USANA Health Sciences Inc
$17.47
-0.21 (-1.19%)
▼
5d:
+2.7%
30d:
-13.04%
90d:
-11.45%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: Apr 28, 2026
27d
Get Alerted When USNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: USNA trading at deep discount. Market pricing in -11.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: USNA trading at deep discount. Market pricing in -11.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$50.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$31.15
43.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USNA is currently trading at $17.47, which is considered slightly low relative to its 30-day fair value range of $16.81 to $20.26. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.4) compared to its historical average (9.3). Remarkably, the market is currently pricing in an annual earnings decline of 11.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, USNA is in a downtrend. The price is approaching resistance at $17.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.00 (+120.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, USNA is in a downtrend. The price is approaching resistance at $17.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.00 (+120.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$16.81 -
$20.26
Company Quality Score
54/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 120.6% below Wall St target ($39.00)
Fair Price Analysis
30-Day Fair Range
$16.81 -
$20.26
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.48
(8.5%)
Support & Resistance Levels
Support Level
$16.76
Resistance Level
$17.79
Current Trend
Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.38
Wall Street Target
$39.00
(+120.6%)
Revenue Growth (YoY)
5.9%
Earnings Growth (YoY)
-3.7%
Profit Margin
1.2%
Valuation Discount vs History
-11.8% cheaper
PE vs Historical
6.4 vs 9.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.8%
(market-implied from PE analysis)
1-Year Target
$15.91
(-10%)
2-Year Target
$14.32
(-19%)
3-Year Target
$12.89
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→9)
$18.78
(+6%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 38.5%)
$164.48
(+830%)
Base:
(SPY PE: 6.4, Growth: 38.5%)
$46.97
(+166%)
Bear:
(PE: 5.4, Growth: 38.5%)
$39.93
(+126%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 29.16 | Current EPS (TTM): $0.58
Bull Case
$37.20
(+114%)
Analyst growth 100.0%, PE expands to 32.1
Base Case
$33.82
(+95%)
Market implied 100.0%, PE stable at 29.2
Bear Case
$11.50
(-34%)
Severe decline -20.0%, PE contracts to 24.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.4 to 9.3
Stabilization Target:
$25.76
(+45.7%)
PE Expansion Potential:
+45.7%
Share & Embed Analysis
Last updated: March 31, 2026 4:03 PM ET
Data refreshes hourly during market hours. Next update: 5:03 PM
Data refreshes hourly during market hours. Next update: 5:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua Foukas
SELL
4461 shares
2026-02-20
David Mulham Mulham
SELL
873 shares
2025-12-10
Frederic J Winssinger
SELL
2000 shares
2025-11-10
Top Rated Packaged Foods Stocks
Top-rated stocks in Packaged Foods by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
FRPT
Freshpet Inc |
STRONG BUY
19 analysts |
$87 | 50 HOLD |
|
DAR
Darling Ingredients Inc |
STRONG BUY
13 analysts |
$62 | 60 BUY |
|
BRBR
Bellring Brands LLC |
STRONG BUY
17 analysts |
$30 | 51 HOLD |
|
CPB
Campbell’s Co |
SELL
23 analysts |
$26 | 55 HOLD |
|
NOMD
Nomad Foods Ltd |
STRONG BUY
7 analysts |
$14 | 60 BUY |
